No Data
No Data
Shandong Polymer Biochemicals: Shandong Polymer Biochemicals' performance forecast for the first half of 2024.
Shandong Polymer Biochemicals (002476.SZ): Expected to make a profit of 53.7-78.4 million yuan in the first half of the year, with a year-on-year turnaround from loss to profit.
On July 12th, Gelunhui reported that Shandong Polymer Biochemicals (002476.SZ) released its performance forecast for the first half of 2024. According to preliminary calculations by the financial department, the net income attributable to shareholders of the listed company in the first half of 2024 is expected to be between 5.37 million yuan and 7.84 million yuan, an increase of 235.55%-297.89% compared to the same period last year; the net income after deducting non-recurring gains and losses is expected to be between 3.2 million yuan and 4.8 million yuan, an increase of 172.49%-208.74% compared to the same period last year. The basic earnings per share are 0.0088 yuan/share - 0.0128 yuan/share. The main reason for the company's performance changes during the reporting period is unclear.
Shandong Polymer Biochemicals (002476.SZ): As of June 28, the total number of shareholders in the company was 42,232.
Shandong Polymer Biochemicals (002476.SZ) stated on its investor platform on July 4th that as of the close of June 28, 2024, the total number of shareholders in the company was 42,232.
Selected announcements from geloncize: shanghai microport endovascular medtech(group)co.,ltd. expects net income to increase by 40% to 50% year-on-year in the first half of the year; cofco biotechnology plans to invest 185 million yuan to expand its Cheng
Investment project: Cofco Biotechnology (000930.SZ): plans to invest 185 million yuan to expand Chengdu company's annual production of 150,000 tons of starch sugar projects. Cofco Biotechnology (000930.SZ) announced that in order to improve the industrial layout of starch sugar business, enhance market share, and improve market competitiveness, the company plans to invest in expanding the COFCO Biochemical (Chengdu) Co., Ltd.'s 150,000 tons/year starch sugar project. The total investment is approximately 185,261.3 million yuan (the final total investment of the project is subject to actual investment). The construction period is 18 months from the date of project approval to successful commissioning. Contract Award: Hongrun Construction Group (00206
Shandong Polymer Biochemicals (002476.SZ): Intends to raise no more than RMB 450 million through a private placement to Sanya Meixin Industry Investment.
On July 1, Gelonhui announced that Baomo Co., Ltd. (002476.SZ) released a plan to issue stocks to specific objects in 2024. The company plans to issue a maximum of 153,583,617 stocks, which is not more than 30% of the company's total shares before this issue. The issue price of this stock is 2.93 yuan/share. The issuer of this stock for specific objects is Merit (Sanya) Industrial Investment Co., Ltd., which will subscribe to the stock issued this time in cash. The total amount of funds raised by the company through this issuance of stock to specific objects will not exceed.
Shandong Polymer Biochemicals (002476.SZ) 2023 equity distribution: 0.1 yuan per 10 shares.
Shandong Polymer Biochemicals (002476.SZ) announced that the equity distribution plan for 2023 is: based on the existing total share capital, distribute RMB 0.1 yuan in cash (tax included) to all shareholders for every 10 shares. The equity distribution registration date for this distribution is June 12, 2024, and the ex-dividend date is June 13, 2024.
No Data